Template:Oral hypoglycemics and insulin analogs
Revision as of 12:08, 21 January 2011 by C Michael Gibson (talk | contribs) (Reverted edits by Harry25594 (Talk) to last version by Zorkun)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Biguanides | |
---|---|
Sulfonylureas | |
Alpha-glucosidase inhibitors | |
Thiazolidinediones (TZD) | |
Meglitinides | |
Dipeptidyl peptidase-4 (DPP-4) inhibitors | |
Glucagon-like peptide-1 analog | Exenatide, Liraglutide†, Albiglutide† |
Amylin analog | |
Insulin analogs | fast acting (Insulin lispro, Insulin aspart, Insulin glulisine), long acting (Insulin glargine, Insulin detemir) |
Dual PPAR agonists | |
SGLT2 inhibitor | Dapagliflozin†, Remogliflozin† |